Immunological Aspect of Ozone in Rheumatic Diseases
|
|
- Dorthy Barnett
- 6 years ago
- Views:
Transcription
1 Immunological Aspect of Ozone in Rheumatic Diseases Prof. Dr. med. Z. Fahmy Chief Consulting Rheumatologist Augusta Clinic for Rheumatic Diseases And Rehabilitation Bad Kreuznach Germany
2 Rheumatoid arthritis is an autoimmune disease Rheumatoid arthritis is associated with immunological and inflammatory mechanisms. The initial, not yet well defined immunological mechanisms lead to inflammatory reactions which alter between acute and chronic stages. Immunological event Cytokines Acute reaction New cytokines Chronic reaction Inflammation New cytokines
3 Exogenous mechanisms Immuno-inflammatory response Endogenous mechanisms Natural predisposition to disease The question of balance Natural host defense Pro-inflammatory cytokines Anti-inflammatory cytokines Symptoms, tissue lesions
4 RA: IMPACT, PATHOGENESIS, AND TREATMENT Cytokine disequilibrium Adapted from Feldmann M et al. Cell 85: , 1996 and Moreland LW et al. Arthritis Rheum 40: , 1997.
5 RA: IMPACT, PATHOGENESIS, AND TREATMENT Physical manifestations Joints usually involved symmetrically, with wrists, MCP joints, and PIP joints most commonly affected 1 Articular manifestations include tenosynovitis, which diminishes strength and flexibility 1,2 Extra-articular manifestations most prevalent when RF is positive; up to 50% of patients demonstrate nodules 1,2 References: 1. Harris ED Jr, in Kelley WN, Harris ED Jr, Ruddy S et al, Textbook of Rheumatology. Vol 1. 4th ed. Philadelphia, Pa: WB Saunders Company, 1993, pp Anderson RJ, in Klippel JH (ed), Primer on the Rheumatic Diseases. 11th ed. Atlanta, Ga: Arthritis Foundation, 1997, pp
6 RA: IMPACT, PATHOGENESIS, AND TREATMENT The inflammatory cascade Activation of T cells triggers a series of intercellular reactions 1 T Cell B Cell Macrophage Lymphocytes and macrophages release proinflammatory cytokines 1,2 Pannus Cytokines induce synovial proliferation and release of destructive enzymes 1,2 Cartilage TNF IL-1 References: 1. Rosenberg AE, in Cotran RS, Kumar V, Robbins SL, Robbins Pathologic Basis of Disease. 5th ed. Philadelphia, Pa: WB Saunders Company, 1994, pp Goronzy JJ, Weyand CM, in Klippel JH (ed), Primer on the Rheumatic Diseases. 11th ed. Atlanta, Ga: Arthritis Foundation, 1997, pp
7 RA: IMPACT, PATHOGENESIS, AND TREATMENT The role of cytokines Serve as natural mediators of cell function 1 Induce production of other cytokines 2 Reduce inflammation by binding to cell-surface receptors or preventing cell activation 3 Soluble TNF receptor TNF IL-1 Cell-surface TNF receptor References: 1. Arend WP, Dayer J, in Kelley WN, Harris ED Jr, Ruddy S et al, Textbook of Rheumatology. Vol 1. 4th ed. Philadelphia, Pa: WB Saunders Company, 1993, pp Baumgartner SW. South Med J 93: , Moreland LW. Cleve Clin J Med 66: , 1999.
8 RA: IMPACT, PATHOGENESIS, AND TREATMENT Importance of targeting TNF The binding of TNF to cell-surface receptors triggers multiple destructive events 1 Soluble TNF receptor TNF Cell-surface receptor TNF induces production of other proinflammatory cytokines, including IL-1 1 Thus, targeting TNF may inhibit the destructive activity of both TNF and other destructive cytokines 2,3 Cell activation References: 1. Moreland LW. J Rheumatol 26(Suppl 57):7-15, Choy EHS, Panayi GS. N Engl J Med 344: , Feldmann M, Brennan FM, Maini RN. Cell 85: , 1996.
9 RA: IMPACT, PATHOGENESIS, AND TREATMENT The central role of TNF Drives events in the inflammatory cascade 1,2 Triggers production of other cytokines, including IL-1 1,2 TNF PROINFLAMMATORY IL-6, IL-8, IFN, LT IL-1 ANTI-INFLAMMATORY IL-4, IL-10, TGF stnfr, sil-1r, IL-1Ra Adapted from Feldmann et al, References: 1. Feldmann M, Brennan FM, Maini RN. Cell 85: , Baumgartner SW. South Med J 93: , 2000.
10 RA: IMPACT, PATHOGENESIS, AND TREATMENT Destructive effects of TNF
11 IL-1 Plays a Pivotal Role in Many Mechanisms of the RA Disease Process Synovial inflammation Bone destruction Impairment of tissue repair process IL-1 Pannus formation Production of prostaglandins and inflammatory mediators Cartilage degradation Dinarello C. N Engl J Med. 2000;343: ; van den Berg W. Ann Rheum Dis. 2000;59(suppl 1)i81-i84; Joosten L et al. J Immunol. 1999;163: ; Gravallese E, Goldring S. Arthritis Rheum. 2000;43: ; Bresnihan B, Dayer J-M. IL-1Ra Therapy in the Treatment of Rheumatoid Arthritis. 2001, Martin Dunitz Ltd, London, UK.
12 RA is Characterised by Synovitis and Joint Destruction Synovial membrane NORMAL RA Inflamed synovial membrane Cartilage Pannus Major cell types: T lymphocytes macrophages Minor cell types: fibroblasts plasma cells endothelium dendritic cells Capsule Synovial fluid Major cell type: neutrophils Cartilage thinning Adapted from Feldmann M, et al. Ann Rev Immunol. 1996;14: ; Pincus T. Drugs. 1995;50(suppl 1):1-14; Tak P, Bresnihan B. Arthritis Rheum. 2000;43:
13 IL-1 Plays a Pivotal Role in the Inflammatory and Destructive Processes of RA IL-1 Activates monocytes/ macrophages Induces fibroblast proliferation Activates chondrocytes Activates osteoclasts Inflammation Synovial pannus formation Cartilage breakdown Bone resorption Dinarello C. N Engl J Med. 2000;343: ; Arend W, Dayer J-M. Arthritis Rheum. 1990;33: ; van den Berg W. Ann Rheum Dis. 2000;59(suppl 1):i81-i84.
14 Role of IL-1 in Joint Destruction IL-1 has a higher potency for inducing joint destruction than TNF 1 In TNF-transgenic mice, arthritis can be completely inhibited by blocking IL-1 signalling 2 TNF-independent IL-1 production has been shown in models 3 No erosive arthritis is observed in IL-1 -deficient mice 4 Spontaneous, destructive arthritis is observed in IL-1Ra-deficient mice 5 1. van de Loo F, et al. Arthritis Rheum. 1995;38: ; 2. Probert L, et al. Eur J Immunol. 1995;25: ; 3. van den Berg W. Ann Rheum Dis. 2000;59(suppl 1):i81-i84; 4. van den Berg W. Semin Arthritis Rheum. 2001;30 (suppl 2):7-16; 5. Horai R, et al. J Exp Med. 2000;191:
15 IL-1 Plays a Central Role in Cartilage Destruction Proteoglycan synthesis (aggrecanase) IL-1 Chondrocyte death (NO, inos) Collagen damage ( prommp-13, type II collagen) Immune complex deposits Cartilage surface erosion (pannus, PMN) inos = inducible nitric oxide synthase; MMP = matrix metalloprotease; NO = nitric oxide; PMN = polymorphonuclear cell Adapted from van den Berg W. Semin Arthritis Rheum. 2001;30(suppl 2):7-16; van den Berg W. Ann Rheum Dis. 2000;59(suppl 1):i81-i84; Dinarello C. Blood. 1996;87:
16 IL-1 Regulates Osteoclast Differentiation and Activity Osteoclast progenitor + IL-1 OPGL + IL-1 induces osteoblast apoptosis IL-1 Osteoblast Osteoclast OPGL = osteoprotegerin ligand BONE Adapted from Tsuboi M, et al. J Lab Clin Med. 1999;134: ; Gravallese E, Goldring S. Arthritis Rheum. 2000;43: ; Gravallese E, et al.arthritis Rheum. 2000;43:
17 The effect of ozone of the immune system 1. The effect of the immune competent cells of the lymphocytes 2. The induction of the cytokin through the effect of the lymphocytes 3. Regulation of the immune system
18
19 Cytokin-Induction (in %) In dependence on ozone concentration oxygen 42 µg 78 µg IL-1 IL-2 GM-CSF
20 RA: IMPACT, PATHOGENESIS, AND TREATMENT The evolving RA treatment paradigm CURRENT APPROACH EARLY TREATMENT EVOLVING PARADIGM EARLY TREATMENT Traditional DMARDs Aggressive DMARD therapy Biologic agent Monotherapy or Combination IF POOR RESPONSE IF POOR RESPONSE IF DISEASE CONTROLLED Add additional DMARDs Add biologic agent Combination therapy Discontinuation/ reduction of DMARDs
21 Study identification and inclusion criteria Groups of patients with Rheumatoid Arthritis each group n = 25 patients 1. Group: NSADs Diclofenac mg 2. Group: Ozone 3 x weekly 3. Group: Ozone + Methotrexat 7,5 15 mg 4. Group: Ozone + Enbrel 50 mg weekly + MTX 7,5 15 mg
22 Mean score (+/-se) Serum CRP concentration (mg/l) over time Ozone MTX MTX+Ozone Study Day
23 Patient assessment of disease activity over time (group 1 and 2) 5 4,5 4 Pain At Rest Tenderness Pain active Mot. Joint Swelling Joint Effusion 3,5 3 2,5 2 1,5 1 0, Study Day
24 5 4,5 4 3,5 Patient assessment of disease activity over time (group 3 and 4) Pain At Rest Tenderness Pain active Mot. Joint Swelling Joint Effusion 3 2,5 2 1,5 1 0, Study Day
25 The effect of different groups of the cytokines % I n h i b i t i o n Diclofenac Ozone MTX+Ozone MTX+Ozone+Enbrel 0 IL-1 IL-6 TNF
26 Improvement baseline, 180 days : MTX-Enbrel-Ozone S e v e r i t y 3,5 3 2,5 2 1,5 1 Pain at rest Tenderness Pain active mot. Joint swelling Joint effusion 0, Days
27 Improvement baseline, 180 days: (without Ozone) S e v e r i t y 3 2,5 2 1,5 1 Pain at rest Tenderness Pain active mot. Joint swelling Joint effusion 0, Days
28 Summary 1. Ozone is more effective in combined form than single form in the treatment of RA 2. Ozone provided efficacy comparable to combination of MTX 3. Rapid significant decrease in CRP and ESR in combined form (MTX and Ozone) than in single form 4. The incidence of clinically significant treatment in relation laboratory abnormalities was similar among treatment groups with NSADs 5. The ability of ozone to reduce level of acute phase Proteins, and Enbrel in the blood was significant greater in combined form than in single form 6. The ozone effect of the cytokines could be due to either inhibition of the production of cytokines or inhibition of response to cytokines 7. Ozone in clinically and biochemical superior in combined form than single form in treatment of RA
29
30 Vielen Dank für Ihre Aufmerksamkeit Thank you for your kind attention
B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?
Rheumatology 2005;44(Suppl. 2):ii3 ii7 B cells: a fundamental role in the pathogenesis of rheumatoid arthritis? doi:10.1093/rheumatology/keh616 The role of T cells in the pathogenesis of RA is well established,
More informationThe Role of IL-1 and Tumor Necrosis Factor-α in Pathogenesis of Rheumatoid Arthritis
RHEUMATOID THE IRAQI POSTGRADUATE ARTHRITIS MEDICAL JOURNAL The Role of IL-1 and Tumor Necrosis Factor-α in Pathogenesis of Rheumatoid Arthritis Eman Sh.Al-Obeidy*, Shatha F. Abdullah** ABSTRACT: BACKGROUND:
More informationAutoimmune Diseases. Betsy Kirchner CNP The Cleveland Clinic
Autoimmune Diseases Betsy Kirchner CNP The Cleveland Clinic Disclosures (financial) No relevant disclosures Learning Objectives Explain the pathophysiology of autoimmune disease Discuss safe administration
More informationClinical and radiological effects of anakinra in patients with rheumatoid arthritis
Rheumatology 2003;42(Suppl. 2):ii22 ii28 doi:10.1093/rheumatology/keg329, available online at www.rheumatology.oupjournals.org Clinical and radiological effects of anakinra in patients with rheumatoid
More information1.0 Abstract. Title. Keywords. Rationale and Background
1.0 Abstract Title A Prospective, Multi-Center Study in Rheumatoid Arthritis Patients on Adalimumab to Evaluate its Effect on Synovitis Using Ultrasonography in an Egyptian Population Keywords Synovitis
More informationMAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt.
MAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt. AUTOIMMUNE DISEASE RA SLE VASCULITIS RELAPSING POLYCHONDRITIS SS DM/PM SJOGREN S SYNDROME RHEUMATOID ARTHRITIS Classically immune mediated
More informationMonoclonal Antibodies in the Management of Rheumatoid Arthritis Prof. John D. Isaacs
John D Isaacs Professor of Clinical Rheumatology Director, Wilson Horne Immunotherapy Centre Newcastle University, UK 1 Rheumatoid arthritis Targeting T-cells Targeting B-cells Costimulation blockade Novel
More informationEfficacy of Anakinra in Bone: Comparison to Other Biologics
Advances In Therapy Volume 19 No. 1 January/February 2002 Efficacy of Anakinra in Bone: Comparison to Other Biologics Stephen A. Paget, M.D. Hospital for Special Surgery Department of Rheumatic Disease
More informationThe September 3, 2001, cover story of
EPIDEMIOLOGY, PATHOPHYSIOLOGY, AND CLINICAL PRESENTATION * Linda Kay Myers, MD ABSTRACT Juvenile idiopathic arthritis (JIA), the most common form of arthritis in children, is an idiopathic autoimmune disease
More informationIL-17 in health and disease. March 2014 PSO13-C051n
IL-17 in health and disease March 2014 PSO13-C051n Originally Researchers Suggested That IL-12 and IL-4 drove Th Cell Differentiation Naïve CD4 + T cell Question: Which of these cell types is responsible
More informationPatient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour
Patient #1 Rheumatoid Arthritis Essentials For The Family Medicine Physician 45 y/o female Morning stiffness in her joints >1 hour Hands, Wrists, Knees, Ankles, Feet Polyarticular, symmetrical swelling
More informationAmino acid sequences in the β chain HLA- DRB*0401 molecules dictate susceptibility to RA Amino Acids in the Shared Epitope
MHC/self-peptide MHC/Vβ TCR Vβx + Vβx T cell Induction of + TH1 mediated autoimmunity: A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and APC type I diabetes TCR Vβx Activated
More informationConcept of Spondyloarthritis (SpA)
Concept of Spondyloarthritis (SpA) Spondyloarthritis: Characteristic Parameters Used for Diagnosis I Symptoms Inflammatory back pain Imaging Lab ESR/CRP Patient s history Good response to NSAIDs Spondyloarthritis-Characteristic
More informationRequirements in the Development of an Autoimmune Disease Amino Acids in the Shared Epitope
+ T cell MHC/self-peptide MHC/Vβ Induction of + T H 1 mediated autoimmunity: A paradigm for the pathogenesis of rheumatoid arthritis, multiple sclerosis and type I diabetes APC Activated autoreactive +
More informationTreating Rheumatologic Disease in Arizona: Good News, Bad News
Treating Rheumatologic Disease in Arizona: Good News, Bad News Jeffrey R. Lisse, M.D. Ethel P. McChesney Bilby Professor of Medicine Chief, Section of Rheumatology University of Arizona School of Medicine
More informationNew Medicine Report. Anakinra Classification RED (Adopted by the CCG until review and further notice) Date of Last Revision 5 th July 2002
New Medicine Report Document Status Anakinra Classification RED (Adopted by the CCG until review and further notice) Post Suffolk D&TC Date of Last Revision 5 th July 2002 Approved Name Trade Name Manufacturer
More informationUltrasound in Rheumatology
Arthritis Research UK Primary Care Centre Winner of a Queen s Anniversary Prize For Higher and Further Education 2009 Ultrasound in Rheumatology Alison Hall Consultant MSK Sonographer/Research Fellow Primary
More informationPATHOGENESIS OF RHEUMATOID ARTHRITIS
PATHOGENESIS OF RHEUMATOID ARTHRITIS Division of Rheumatology Department of Internal Medicine College of Medicine Seoul National University Seoul National University Bundang Hospital Yun Jong Lee Rheumatoid
More informationCOMPARATIVE CYTOKINE GENE EXPRESSION IN SYNOVIAL TISSUE OF EARLY RHEUMATOID ARTHRITIS AND SERONEGATIVE SPONDYLOARTHROPATHIES
British Journal of Rheumatology 1997;36:38 42 COMPARATIVE CYTOKINE GENE EXPRESSION IN SYNOVIAL TISSUE OF EARLY RHEUMATOID ARTHRITIS AND SERONEGATIVE SPONDYLOARTHROPATHIES J. D. CAN ETE, J. LLENA, A. COLLADO,
More informationBiologic agents in Internal Medicine-2018: Targeted therapies for.
Biologic agents in Internal Medicine-2018: Targeted therapies for. Chronic inflammatory diseases affecting the skin Chronic inflammatory diseases affecting the gut Chronic inflammatory diseases affecting
More informationPATHOGENESIS OF RHEUMATOID ARTHRITIS
PATHOGENESIS OF RHEUMATOID ARTHRITIS Division of Rheumatology Department of Internal Medicine College of Medicine Seoul National University Seoul National University Bundang Hospital Yun Jong Lee Rheumatoid
More informationRheumatoid Arthritis. Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011
Rheumatoid Arthritis Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011 The security of experience. The power of innovation. www.rgare.com Case Study
More informationPotential Role of Sphingosine 1-Phosphate in the. Pathogenesis of Rheumatoid Arthritis
Potential Role of Sphingosine 1-Phosphate in the Pathogenesis of Rheumatoid Arthritis COMMENTARY for Zhao, C., Fernandes, M.J., Turgeon, M., Tancrede, S., Di Battista, J., Poubelle, P.E. and Bourgoin,
More informationThe Rheumatoid Hand Deformities & Management. Dr. Anirudh Sharma Resident Department of Orthopedics
+ The Rheumatoid Hand Deformities & Management Dr. Anirudh Sharma Resident Department of Orthopedics + Why is Rheumatoid Arthritis important? + RA is a very debilitating disease median life expectancy
More informationCytokines, adhesion molecules and apoptosis markers. A comprehensive product line for human and veterinary ELISAs
Cytokines, adhesion molecules and apoptosis markers A comprehensive product line for human and veterinary ELISAs IBL International s cytokine product line... is extremely comprehensive. The assays are
More informationA. Kopchev, S.Monov, D. Kyurkchiev, I.Ivanova, T. Georgiev (UMHAT St. Ivan Rilski, Medical University - Sofia, Bulgaria)
International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 6718, ISSN (Print): 2319 670X Volume 6 Issue 7 July 2017 PP. 08-12 Vascular endothelial growth factor (VEGF), cartilage oligomeric
More informationThe role of interleukin-1 in the pathogenesis of rheumatoid arthritis
Rheumatology 2004;43(Suppl. 3):iii2 iii9 The role of interleukin-1 in the pathogenesis of rheumatoid arthritis J. Kay and L. Calabrese 1 doi:10.1093/rheumatology/keh201 A significant body of experimental
More informationI n the past, analgesics and nonsteroidal
Rituximab in advanced rheumatoid arthritis Michael Guida BSc, MA Rheumatoid arthritis (RA) continues to have a major impact on public health. Costs to the individual and to the NHS are high, and treatment
More informationRheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904)
Rheumatoid Arthritis Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904) 503-6999. 1 Disclosures Speaker Bureau: Abbvie 2 Objectives Better understand the pathophysiology
More informationOsteoclasts are essential for TNF-α mediated joint destruction
Osteoclasts are essential for TNF-α mediated joint destruction Kurt Redlich, 1 Silvia Hayer, 2 Romeo Ricci, 3 Jean-Pierre David, 3 Makiyeh Tohidast-Akrad, 4 George Kollias, 5 Günter Steiner, 1 Josef S.
More informationEtanercept: therapeutic use in patients with rheumatoid arthritis
nn Rheum Dis 1999;8:(Suppl I) I6 I69 I6 Immunex Corporation, Seattle, W, US Correspondence to: Dr N D McDonnell, Immunex Corporation, 1 University Street, Seattle, W 9811, US. Etanercept: therapeutic use
More informationRheumatoid arthritis
Rheumatoid arthritis 1 Definition Rheumatoid arthritis is one of the most common inflammatory disorders affecting the population worldwide. It is a systemic inflammatory disease which affects not only
More informationWhen is it Rheumatoid Arthritis When to Refer
When is it Rheumatoid Arthritis When to Refer Nancy A. Brown, DO Spring 2015 When is it Rheumatoid Arthritis When to Refer Learning objectives To review the definition and epidemiology of Rheumatoid Arthritis
More informationSIGNIFICANCE OF ELEVATED INTERLEUKIN-6 LEVEL IN JUVENILE RHEUMATOID ARTHRITIS PATIENTS
SIGNIFICANCE OF ELEVATED INTERLEUKIN-6 LEVEL IN JUVENILE RHEUMATOID ARTHRITIS PATIENTS Essam Tewfik Attwa and S. Al-Beltagy* Rheumatology & Rehabilitation Department, Zagazig University Faculty of Medicine
More informationRheumatology and Internal Diseases Clinic of the Central Clinical Hospital in Warsaw 137 Woloska St. WARSAW POLAND prof. Małgorzata Wisłowska
Rheumatology and Internal Diseases Clinic of the Central Clinical Hospital in Warsaw 137 Woloska St. WARSAW 02-507 POLAND prof. Małgorzata Wisłowska MD, PhD 1 Klinika Chorób Wewnętrznych i Reumatologii
More informationUsing ENBREL to Treat Rheumatoid and Psoriatic Arthritis
Using ENBREL to Treat Rheumatoid and Psoriatic Arthritis Writing White Papers class Bellevue Community College TABLE OF CONTENTS TABLE OF CONTENTS...2 OVERVIEW...3 RHEUMATOID ARTHRITIS... 3 JUVENILE RHEUMATOID
More informationTypes of osteoarthritis
ARTHRITIS Osteoarthritis is a degenerative joint disease is the most common joint disorder. It is a frequent part of aging and is an important cause of physical disability in persons older than 65 years
More informationRheumatoid Arthritis
Rheumatoid Arthritis Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Autoimmune diseases are illnesses that occur when the body's tissues are mistakenly
More informationMethotrexate as an Alternative Therapy for Chronic Calcium Pyrophosphate Deposition Disease
ARTHRITIS & RHEUMATISM Vol. 56, No. 2, February 2007, pp 688 692 DOI 10.1002/art.22389 2007, American College of Rheumatology Methotrexate as an Alternative Therapy for Chronic Calcium Pyrophosphate Deposition
More informationI nuovi criteri ACR/EULAR per la classificazione dell artrite reumatoide
I nuovi criteri ACR/EULAR per la classificazione dell artrite reumatoide Pierluigi Macchioni Struttura Complessa di Reumatologia, Ospedale di Reggio Emilia Topics 1987 ACR classification criteria for RA
More informationBone Cell Precursors and the Pathophysiology of Bone Loss
Bone Cell Precursors and the Pathophysiology of Bone Loss HARRY C. BLAIR, a AND JILL L. CARRINGTON b a Departments of Pathology and Cell Biology, University of Pittsburgh, and Pittsburgh VA Medical Center,
More informationThe Pathogenesis of Bone Erosions in RA FULL VERSION
The Pathogenesis of Bone Erosions in RA FULL VERSION 1 Key Learning Objectives Understand the role of osteoclasts in normal bone remodeling Comprehend the key processes in pathologic osteoclast functions
More informationClinical Policy: Tocilizumab (Actemra) Reference Number: ERX.SPMN.44
Clinical Policy: (Actemra) Reference Number: ERX.SPMN.44 Effective Date: 10/16 Last Review Date: 09/16 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory
More informationDiscovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04690) as a Potential Disease Modifying Treatment for Knee Osteoarthritis
Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM469) as a Potential Disease Modifying Treatment for Knee Osteoarthritis Vishal Deshmukh, Ph.D., Charlene Barroga, Ph.D., Yong Hu, Ph.D., John
More informationRole of Cytokines in Pathogenesis of Rheumatoid Arthritis
ISSN 0976 3333 Available Online at www.ijpba.info International Journal of Pharmaceutical & Biological Archives 2017; 8(6): 31-36 REVIEW ARTICLE Role of Cytokines in Pathogenesis of Rheumatoid Arthritis
More informationAUTOIMMUNITY CLINICAL CORRELATES
AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel
More information322 J App Pharm Vol. 6; Issue 3: ; July, 2014 Haque et al, 2014
322 J App Pharm Vol. 6; Issue 3: 322-326; July, 2014 Haque et al, 2014 Original Research Article EVALUATION OF BIOCHEMICAL MARKER FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS *S.S.Haque, Santosh Kumar, Rekha
More informationAUTOIMMUNITY TOLERANCE TO SELF
AUTOIMMUNITY CLINICAL CORRELATES Pamela E. Prete, MD, FACP, FACR Section Chief, Rheumatology VA Healthcare System, Long Beach, CA Professor of Medicine, Emeritus University of California, Irvine Colonel
More informationKelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition
Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition Firestein, G ISBN-13: 9781437717389 Table of Contents VOLUME I STRUCTURE AND FUNCTION OF BONE,
More informationHigh Impact Rheumatology
High Impact Rheumatology Evaluation and Management of Rheumatoid Arthritis Rheumatoid Arthritis: Key Features Symptoms >6 weeks duration Often lasts the remainder of the patient s life Inflammatory synovitis
More informationOSTEOARTHRITIS: A LOOK AT PATHOPHYSIOLOGY AND APPROACH TO NEW TREATMENTS: A REVIEW
REVIEW East African Orthopaedic Journal OSTEOARTHRITIS: A LOOK AT PATHOPHYSIOLOGY AND APPROACH TO NEW TREATMENTS: A REVIEW S. H. Hassanali, MBBS, MMed, Consultant Physician, Aga Khan University Hospital,
More informationEtiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis
Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis JIA is the most common rheumatic disease in childhood and a major cause of chronic disability. Etiology: Unknown, but may
More informationElevated level of interleukin-29: A proinflammatory role in synovial inflammation of rheumatoid arthritis
Advances in Biochemistry 2014; 2(2): 29-33 Published online April 20, 2014 (http://www.sciencepublishinggroup.com/j/ab) doi: 10.11648/j.ab.20140202.11 Elevated level of interleukin-29: A proinflammatory
More informationConcordance with the British Society of Rheumatology (BSR) 2010 recommendations on eligibility criteria for the first biologic agent
Concordance with the British Society of Rheumatology (BSR) 2010 recommendations on eligibility criteria for the first biologic agent Michela Frendo, John Paul Caruana Galizia, Andrew A Borg Abstract Aims:
More informationSynoviocytes. Macrophage. B cell C H R O N I C. Neutrophil. Mast cell I N F L A M M A T I O N. Tissue cell. Endothelial cell. Th1/Th17 IL17 IL22
DC IL12, IL23 chemokines, ECM, Co-stimulation IL17, IL22 IFNγ ± Macrophage peptidoglycan lipopolysaccharide heat shock proteins Th1/Th17 IL17 IL22 Cell contact, co-stimulation immune complexes acute phase
More informationImmunology for the Rheumatologist
Immunology for the Rheumatologist Rheumatologists frequently deal with the immune system gone awry, rarely studying normal immunology. This program is an overview and discussion of the function of the
More informationDiscovery of a Small Molecule Inhibitor of the Wnt Pathway as a Potential Disease Modifying Treatment for Knee Osteoarthritis
Discovery of a Small Molecule Inhibitor of the Wnt Pathway as a Potential Disease Modifying Treatment for Knee Osteoarthritis Charlene Barroga, Ph.D., Yong Hu, Ph.D., Vishal Deshmukh, Ph.D., and John Hood,
More informationCYTOKINES. Based on: Cellular and Molecular Immunology, 4 th ed.,abbas A.K., Lichtman A.H. and Pober J.S. Sounders company; Philadelphia, 2010.
CYTOKINES Based on: Cellular and Molecular Immunology, 4 th ed.,abbas A.K., Lichtman A.H. and Pober J.S. Sounders company; Philadelphia, 2010. 1 What are cytokines? Glycoproteins (15 25 kda): Interleukins
More informationMMS Pharmacology Lecture 2. Antirheumatic drugs. Dr Sura Al Zoubi
MMS Pharmacology Lecture 2 Antirheumatic drugs Dr Sura Al Zoubi Revision Rheumatoid Arthritis Definition (RA): is the most common systemic inflammatory disease characterized by symmetrical inflammation
More informationInflammation in OA. Osteoarthritis. Crystals found in synovial fluid. Calcium-containing crystals in OA 10/28/2013. I have no disclosures
Dublin Academic Medical Centre Dublin Academic Medical Centre How Do Calcium Crystals Induce Inflammation and Contribute to Osteoarthritis I have no disclosures Geraldine McCarthy MD, FRCPI Clinical Professor
More informationp. 70 p. 94 p. 102 p. 105 p. 108
European League Against Rheumatism EULAR - a vehicle for communication p. 3 EULAR - a vehicle for communication; the role of ILAR p. 8 Overview on the Scientific Basis of Rheumatic Diseases Molecular and
More informationA 3-page standard protocol to evaluate rheumatoid arthritis (SPERA): Efficient capture of essential data for clinical trials and observational studies
A 3-page standard protocol to evaluate rheumatoid arthritis (SPERA): Efficient capture of essential data for clinical trials and observational studies T. Pincus Division of Rheumatology and Immunology,
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Correlation between Plasma Interleukin-18 Level and Disease Activity in Jordanian Patients
More informationLABORATORY STANDARDS IN DIAGNOSIS AND THERAPY MONITORING OF RHEUMATOID ARTHRITIS
LABORATORY STANDARDS IN DIAGNOSIS AND THERAPY MONITORING OF RHEUMATOID ARTHRITIS Andrea Tešija- Kuna, M.Sc. Clinical Institute of Chemistry, School of Medicine University of Zagreb & Sestre milosrdnice
More information4 2 Osteoarthritis 1
Osteoarthritis 1 Osteoarthritis ( OA) Osteoarthritis is a chronic disease and the most common of all rheumatological disorders. It particularly affects individuals over the age of 65 years. The prevalence
More informationCytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:
Cytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Learning Objectives By the end of this lecture you will be able to: 1 Understand the physiological
More informationRheumatoid Arthritis Update
Rheumatoid Arthritis Update Beth Valashinas, DO, FACOI, FACR Disclosures Speaker for AbbVie Pharmaceuticals Learning Objectives Upon completion of this session, participants should be able to discuss:
More informationMOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism
MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism SCHMAIEL SHIRDEL CONTENT 2 Introduction Autoimmune diseases Classification Involved components Autoimmune
More informationFocal Infection Theory
Paradigm Shift Focal Infection Theory 1900, British physician William Hunter first developed the idea that oral microorganisms were responsible for a wide range of systemic conditions that were not easily
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: abatacept_orencia 4/2008 2/2018 2/2019 2/2018 Description of Procedure or Service Abatacept (Orencia ), a
More informationInnate immune regulation of T-helper (Th) cell homeostasis in the intestine
Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Masayuki Fukata, MD, Ph.D. Research Scientist II Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation,
More informationPathophysiologic Basis of Autoimmune Disorders
Pathophysiologic Basis of Autoimmune Disorders Linda Felver, Ph.D., R.N. Associate Professor School of Nursing Oregon Health & Science University The immune system has two arms: Adaptive (Acquired) Immune
More informationReview Article. Treatment of Rheumatoid Arthritis in the New Millennium. Introduction. Pathogenesis of RA. Ernest HS Choy
Review Article Treatment of Rheumatoid Arthritis in the New Millennium Ernest HS Choy Abstract: Rheumatoid arthritis is a major cause of disability. The prognosis is poor despite treatment by disease modifying
More informationA SURVEY ON RHEUMATOID ARTHRITIS
Abstract A SURVEY ON RHEUMATOID ARTHRITIS Praveen Kumar Patel*, Upendra Bhadoriya College of pharmacy, IPS Academy, Rajendra nagar, Indore 452012, india Rheumatoid Arthritis (RA) is an autoimmune disease
More informationUnderstanding Rheumatoid Arthritis
Understanding Rheumatoid Arthritis Contents Introduction...3 What is rheumatoid arthritis?...4 Symptoms of rheumatoid arthritis... 5 What causes rheumatoid arthritis?... 10 The role of genes and family
More informationThe interleukin-23/interleukin-17 axis and the role of Treg/ Th17 cells in rheumatoid arthritis and joint destruction
Rheumatic Diseases Page 1 of 6 The interleukin-23/interleukin-17 axis and the role of Treg/ Th17 cells in rheumatoid arthritis and joint destruction S AlFadhli* Abstract Introduction Rheumatoid arthritis
More informationInterleukin-6 (IL-6) is a multifunctional cytokine that
S11 Interleukin-6 A Key Mediator of Systemic and Local Symptoms in Rheumatoid Arthritis Bruce N. Cronstein, M.D. Abstract Interleukin-6 (IL-6) is a pleiotropic cytokine, present at elevated levels in patients
More informationGolimumab: In Combination with Methotrexate as Once Monthly Treatment for Moderate to Severe Rheumatoid Arthritis
Clinical Medicine Reviews in Therapeutics Review Golimumab: In Combination with Methotrexate as Once Monthly Treatment for Moderate to Severe Rheumatoid Arthritis Lauren Keyser McCluggage 1 and Kelly Michelle
More informationIN T RO D U C T I O N
AN OVERVIEW OF RHEUMATOID ARTHRITIS Michele Boutaugh, BSN, MPH* ABSTRACT Rheumatoid arthritis is a systemic autoimmune disease characterized by chronic inflammation that damages synovial joints, especially
More informationApolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis
Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis F. Oliviero 1, P. Sfriso 1, G. Baldo 2, J.-M. Dayer 4, S. Giunco 2, A.
More informationEquine Regenerative Medicine. Regenerative Medicine IRAP and PRP in the Equine Athlete. Stem Cells. Stem Cells. Veterinary Medical Devices
Equine Regenerative Medicine Regenerative Medicine IRAP and PRP in the Equine Athlete Victoria Maxwell, DVM, MBA 2018 Potomac Regional Veterinary Conference Hyatt Regency Inner Harbor Baltimore, Maryland
More informationFor more information about how to cite these materials visit
Author(s): David A. Fox, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-Commercial 3.0 License: http://creativecommons.org/licenses/by-nc/3.0/
More informationRheumatoid Arthritis. Improving Outcomes in RA: Three Pillars. RA: Chronic Joint Destruction and Disability What We Try to Prevent
Rheumatoid Arthritis Modern Management of Common Problems in Rheumatology: Rheumatoid Arthritis Jonathan Graf, M.D. Associate Professor of Medicine, UCSF Division of Rheumatology, SFGH Director, UCSF Rheumatoid
More informationThe medical treatment of rheumatoid arthritis has been dramatically improved with the
DOI: 10.5124/jkma.2010.53.10.871 pissn: 1975-8456 eissn: 2093-5951 http://jkma.org Focused Issue of This Month Medical treatment of rheumatoid arthritis (I): Nonsteroidal anti-inflammatory drugs, disease
More informationStudies of molecular mechanisms of action of TNF antagonists in rheumatoid arthritis Anca Irinel Catrina, MD
Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden Studies of molecular mechanisms of action of TNF antagonists in rheumatoid arthritis
More informationLOCALLY AVAILABLE BIOLOGIC AGENTS IN THE TREATMENT OF PSORIATIC ARTHRITIS
Locally Available Biologic Agents in the Treatment of Psoriatic Arthritis 253 Phil. J. Internal Medicine, 47: 253-259, Nov.-Dec., 2009 LOCALLY AVAILABLE BIOLOGIC AGENTS IN THE TREATMENT OF PSORIATIC ARTHRITIS
More informationScintigraphic Findings and Serum Matrix Metalloproteinase 3 and Vascular Endothelial Growth Factor Levels in Patients with Polymyalgia Rheumatica
The Open General and Internal Medicine Journal, 29, 3, 53-57 53 Open Access Scintigraphic Findings and Serum Matrix Metalloproteinase 3 and Vascular Endothelial Growth Factor Levels in Patients with Polymyalgia
More informationAnnual Rheumatology & Therapeutics Review for Organizations & Societies
Annual Rheumatology & Therapeutics Review for Organizations & Societies Comparative Effectiveness Studies of Biologics Learning Objectives Understand the motivation for comparative effectiveness research
More informationJuvenile Idiopathic Arthritis (JIA)
Juvenile Idiopathic Arthritis (JIA) Kaveh Ardalan, MD, MS Division of Rheumatology Ann & Robert H. Lurie Children s Hospital of Chicago Assistant Professor, Pediatrics and Medical Social Sciences Northwestern
More informationEARLY INFLAMMATORY RESPONSES TO VASCULAR DEVICES
EARLY INFLAMMATORY RESPONSES TO VASCULAR DEVICES JAMES M. ANDERSON, MD, PhD DISTINGUISHED UNIVERSITY PROFESSOR DEPARTMENTS OF PATHOLOGY, MACROMOLECULAR SCIENCE, AND BIOMEDICAL ENGINEERING CASE WESTERN
More informationPharmaceutical pathology
Pharmaceutical pathology Livia Vida 2018 1. Necrosis, types, examples. Apoptosis. 2. Adaptations I. Degeneration, atrophy. 3. Adaptations II. Hypertrophy, hyperplasia. 4. Pigments. Calcification. 5. Inflammation
More informationClinical significance of interleukin-32 expression in patients with rheumatoid arthritis
Original article Clinical significance of interleukin-32 expression in patients with rheumatoid arthritis Ming Gui, Hao Zhang, Kuangbiao Zhong, Ying Li, Jian Sun and Li Wang Summary Objective To explore
More informationAntibodies to type II collagen in SLE: A role in the pathogenesis of deforming arthritis?
Immunol. Cell Biol. (1990)68, 27-31 Antibodies to type II collagen in SLE: A role in the pathogenesis of deforming arthritis? Edward K. K. Choi,' Paul A. Gatenby,' John F. Bateman2 and William G. ^Clinical
More informationAIMS We will all come across osteo- and rheumatoid arthritis whatever our clinical practice Overview of pathology of osteoarthritis, its assessment an
Osteoarthritis and Rheumatoid Arthritis Mr. Guy Barham FY1 & FY2 Orthopaedic Curriculum June 2007 AIMS We will all come across osteo- and rheumatoid arthritis whatever our clinical practice Overview of
More informationBringing the clinical experience with anakinra to the patient
Rheumatology 2003;42(Suppl. 2):ii36 ii40 doi:10.1093/rheumatology/keg331, available online at www.rheumatology.oupjournals.org Bringing the clinical experience with anakinra to the patient S. B. Cohen
More informationInflammatory arthritis Shared Decision Making
Inflammatory arthritis Shared Decision Making DMARDs El Miedany et al. Ann Rheum Dis 74(Suppl2): 1002 DOI: 10.1136/annrheumdis-2015-eular.1410 www.rheumatology4u.com Copyrights reserved Contents 1 2 3
More informationof 0.20) and Health assessment questionnaire disability index (HAQ-DI) (r partial
IL-6 receptor inhibition modulates type III collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of
More informationNBQX, An AMPA/Kainate Glutamate Receptor Antagonist, Alleviates Joint Disease In Models Of Inflammatory- And Osteo- Arthritis.
NBQX, An AMPA/Kainate Glutamate Receptor Antagonist, Alleviates Joint Disease In Models Of Inflammatory- And Osteo- Arthritis. Cleo S. Bonnet, PhD 1, Anwen S. Williams, PhD 1, Sophie J. Gilbert, PhD 1,
More informationRheumatoid Arthritis: An update for non rheumatologists
Rheumatoid Arthritis: An update for non rheumatologists Dimitrios Pappas, M.D., M.P.H. Assistant Professor of Medicine Columbia University, College of Physicians & Surgeons Director of Rheumatology Athens
More information